Gadavist 10 mmol/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AL5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,782
Award facts
- Contract value 100% obligated
- $2,782.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,782.20 by the Defense Logistics Agency on January 22, 2026, for the supply of Gadavist 10 mmol/10 mL vials. This firm fixed-price delivery order is not set aside and is expected to be completed by January 23, 2026. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which holds the parent Indefinite Delivery Contract with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031. The company's federal contracting portfolio demonstrates its capability to efficiently fulfill government procurement requirements for essential pharmaceutical and medical commodities across multiple therapeutic domains, serving critical federal healthcare systems including the Defense Health Agency, Department of Veterans Affairs, and U.S. Coast Guard. The delivery order for Gadavist, a diagnostic imaging contrast agent, exemplifies the company's role in supplying specialized medical products to support military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F1AL5?
SPE2DR26F1AL5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F1AL5 worth?
The government has obligated $2,782 on SPE2DR26F1AL5.
Is contract SPE2DR26F1AL5 an order under another contract?
Yes. SPE2DR26F1AL5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AL5 competed?
The extent of competition for SPE2DR26F1AL5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award